Fast Forward begins two Phase II trials of FFP104 in PBC and Crohn’s disease patients

Fast Forward Pharmaceuticals has started two Phase II clinical trials of FFP104, a potential treatment for patients with primary biliary cirrhosis (PBC) and Crohn's disease.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news